Skin lightening composition
The skin hyperpigmentation and inhomogeneity problems are solved through the composition of retinoic acid precursor, carboxylic acid functionalized aromatic heterocyclic compounds, alkyl resorcinol and inulin, and the skin tone is achieved uniformly and brightly radiant at low doses Effects, and improve product stability and reduce costs.
Patent Information
- Application Number
- CN202380026942.4
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Priority Date
- 2022-03-18
- Filing Date
- 2023-03-16
- Publication Date
- 2024-11-08
AI Technical Summary
The prior art is difficult to effectively solve the problems of excessive and uneven skin pigmentation caused by exposure to sunlight, and the use of conventional skin care active substances is high and costly, and the formulations are poorly stable.
Using a composition of retinoic acid precursor, carboxylic acid functionalized aromatic heterocyclic compounds, alkyl resorcinol and inulin, the composition is applied to the skin to reduce pigment production, providing a uniform and bright complexion, And the use of active substances is reduced through the synergistic action of inulin, and the stability of the formulation is improved.
It achieves effective reduction of skin pigmentation at low doses, provides uniform and bright skin tone effects, while improving the formulation stability of skin care products and reducing costs.
Smart Images

Figure BDA0005038068070000051
Abstract
Description
Technical Field
[0001] The present invention relates to personal care compositions for lightening the skin. More particularly, the present invention relates to topical compositions effective against hyperpigmentation, particularly caused by exposure to the sun. Background Art
[0002] Most people regard skin appearance, especially the skin appearance on the face, as one of the key indicators of their own beauty and health. Therefore, many people expect to have a bright and flawless uniform skin color. The degree and uniformity of the pigmentation of the skin are subject to factors such as age, hormone changes, the occurrence of acne and exposure to sunlight and pollution. These can cause spots or freckles, excessive pigmentation on specific local areas of the skin and dark circles under the eyes. Many people believe that specific lifestyle factors, such as hydration (amount of water consumed), the type of food and the quantity and quality of sleep, also can affect the appearance of the skin, including the dark circles under the eyes. Because people realize that changes like living a healthier lifestyle may take a long time to make the skin appearance uniform, they rely on cosmetic solutions to give them temporary solutions for the flaws on their skin. They also seek such products to reduce the darkening of the skin caused by exposure to sunlight. In order to meet this need, many attempts have been made to develop products that reduce the pigment production in melanocytes.
[0003] The inventors have been working in this field for a long time and have also filed several patent applications and produced various cosmetic products on the market. In the present invention, they specifically looked for an efficient solution to this problem, which can also be used as a general cosmetic product for providing an even and bright skin tone, especially on exposed skin surfaces.
[0004] They wanted to ensure that the product they developed was as effective as the most effective products on the market, if not better. After screening a large number of actives, they found that one or more of skin care actives known to provide an even skin tone, such as alkylresorcinols or carboxylic acid functionalized aromatic heterocyclic compounds or retinoic acid compounds known for anti-aging benefits, when combined with inulin, provided enhanced skin lightening and even skin tone. To the best of the inventors' knowledge, this combination of actives that provided this benefit was previously unknown. In addition, it is desirable to include conventional skin care actives known for such benefits, such as alkylresorcinols or carboxylic acid functionalized aromatic heterocyclic compounds or retinoic acid compounds, typically in lower amounts, and this not only reduces cost, but also ensures better compatibility with other ingredients in the formulation, thereby leading to better formulation stability. The inventors are looking for a solution in which additives that work synergistically with the above conventional skin care actives can be identified so that these actives can be included at very low concentrations, thereby providing all of the above advantages.
[0005] It is therefore an object of the present invention to provide a solution to the problem of hyperpigmentation and uneven skin appearance, thereby providing a brighter skin appearance.
[0006] Another object of the present invention is to provide a solution involving the inclusion of lower amounts of skin care actives, thereby ensuring better formulation stability. Summary of the invention
[0007] A first aspect of the present invention relates to a personal care composition comprising:
[0008] (i) a retinoic acid precursor selected from one or more of retinol esters, retinol, retinal and retinoic acid; (ii) a carboxylic acid functionalized aromatic heterocyclic compound selected from one or more of nicotinic acid, picolinic acid, nicotinic acid esters, nicotinamide and pyridineamide; and (iii) an alkylresorcinol; (iv) inulin; and (v) a cosmetically acceptable carrier.
[0009] Another aspect of the present invention relates to a method of providing lightness to the skin comprising the step of applying to the skin the composition of the first aspect. DETAILED DESCRIPTION
[0010] By reading the following detailed description and the appended claims, these and other aspects, features and advantages will become apparent to those of ordinary skill in the art. For the avoidance of doubt, any feature of one aspect of the present invention may be used in any other aspect of the present invention. The word "comprising" is intended to mean "including", but not necessarily "consisting of" or "consisting of". In other words, the steps or options listed do not have to be exhaustive. It should be noted that the embodiments given in the following description are intended to illustrate the present invention, but are not intended to limit the present invention to those embodiments themselves. Similarly, unless otherwise indicated, all percentages are weight / weight percentages. Except in the examples and comparative examples, or in the case of otherwise clearly indicated, all numerical values indicating the amount of material or the conditions of reaction, the physical properties of the material and / or the use in this specification and claims should be understood to be modified by the word "about". The numerical range expressed in the format "x to y" should be understood to include x and y. When multiple preferred ranges are described in the format of "x to y" for a particular feature, it should be understood that all ranges combining different endpoints are also considered.
[0011] The composition of the present invention is intended for personal care or cosmetic purposes, and may also be referred to as a personal care composition or a cosmetic composition. "Personal care composition" as used herein means a composition including a composition for topical application, i.e., the outer surface of human skin. Such a composition may be classified as a leave-on type or a rinse-off type, and includes any product applied to the human body for improving appearance, cleaning, odor control, or general aesthetics. The composition is preferably a leave-on type. The composition of the present invention may be in the form of a liquid, lotion, cream, foam, stick, serum, essence, or gel. Preferred compositions include leave-on gels, lotions, serums, or creams, preferably in the form of serums or creams.
[0012] As used herein, "skin" is meant to include the skin on the face and body (eg, neck, chest, back, arms, underarms, hands, legs, and scalp), and particularly means exposed portions thereof.
[0013] The present invention provides a personal care composition comprising (i) a retinoic acid precursor; (ii) a carboxylic acid functionalized aromatic heterocyclic compound selected from one or more of niacin, picolinic acid, nicotinate, niacinamide and pyridineamide; (iii) an alkylresorcinol; (iv) inulin; and (v) a cosmetically acceptable carrier.
[0014] According to the retinoic acid precursor of the present invention, can be selected from one or more of retinol ester, retinol, retinal and retinoic acid, preferably retinal or retinol ester.The example of retinol ester suitable for use in the present invention includes but is not limited to: retinol palmitate, retinol formate, retinol acetate, retinol propionate, retinol butyrate, retinol valerate, retinol isovalerate, retinol hexanoate, retinol enanthate, retinol octanoate, retinol nonanoate, retinol decanoate, retinol undecanoate (undecandate), retinol taurate, retinol tridecanoate, retinol myristate, retinol pentadecanoate, retinol heptadecanoate (retinyl heptadeconoate), retinol stearate, retinol isostearate, retinol nonadecanoate, retinol arachidonic acid ester, retinol behenate, retinol linoleate and retinol oleate. Preferred esters for use in the present invention are selected from retinyl palmitate, retinyl acetate, retinyl propionate and mixtures thereof. Retinyl linoleate and retinyl oleate are also preferred. The most preferred retinoic acid precursor is retinyl propionate. The retinoic acid precursor is used in the composition of the present invention in an amount of 0.001% to 10%, preferably in an amount of 0.01% to 1%, and most preferably in an amount of 0.01% to 0.5%.
[0015] The composition of the present invention may contain a carboxylic acid functionalized aromatic heterocyclic compound. The carboxylic acid functionalized aromatic heterocyclic compound may be selected from one or more of nicotinic acid, picolinic acid, nicotinic acid esters, nicotinamide and pyridine amide. It is preferably one or both of nicotinamide and pyridine carboxamide, most preferably nicotinamide. The carboxylic acid functionalized aromatic heterocyclic compound is typically included in an amount of 0.01% to 10%, preferably 0.05% to 7%, more preferably 0.1% to 5% by weight of the cosmetic composition, including all ranges contained therein.
[0016] Resorcinol is a dihydroxyphenol compound (i.e. 1,3-dihydroxybenzene) characterized by alcohol groups (-OH) at positions 1 and 3. The chemical structure of resorcinols can be modified to give substituted resorcinols characterized by at least one substituent at positions 2, 4, 5 or 6. Preferably, resorcinol comprises at least one substituent comprising 2 to 11 carbon atoms, preferably 2 to 8 carbon atoms, most preferably 2 to 6 carbon atoms. It is particularly preferred that at least one substituent comprises an alkyl group, more preferably an unsaturated alkyl group. The resorcinol compounds comprised in the cosmetic composition of the present invention are oil-soluble alkyl resorcinols.
[0017] Preferably, the resorcinol of the cosmetic composition is substituted with an alkyl group only at the 4-position, i.e., the resorcinol is an alkyl resorcinol, more preferably a 4-substituted alkyl resorcinol. Illustrative but non-limiting examples of 4-substituted alkyl resorcinols include 4-ethyl resorcinol, 4-hexyl resorcinol, 4-phenylethyl resorcinol, 4-cyclopentyl resorcinol, 4-cyclohexyl resorcinol, 4-octyl resorcinol, and mixtures thereof. More preferred alkyl resorcinols for use in the present invention are one or both of 4-ethyl resorcinol and 4-hexyl resorcinol; most preferably 4-hexyl resorcinol. The composition comprises 0.001 to 10% of alkyl resorcinol by weight of the cosmetic composition, preferably 0.01 to 5%, most preferably 0.01 to 1% of alkyl resorcinol, including all ranges contained therein.
[0018] Inulin is a polysaccharide composed of 2 to 60 fructose units and a terminal glucose molecule. Inulin is a generic name covering all β-(2,1) fructans. Inulin has the general structure given below.
[0019]
[0020] Inulin is naturally present in many common plants, such as chicory, Jerusalem artichoke, onion, garlic, barley, rye and wheat. It is present in large quantities in chicory and is usually extracted from chicory for commercial production. It is a well-known prebiotic with antibacterial and anticancer activity. Inulin is accepted as a food ingredient in most countries, which can be used in food formulations without restriction. It is present in skin care compositions as a humectant and moisturizer. It has a CAS number of 9005-80-5. It has the IUPAC name fructosane. Inulin is preferably included in the composition of the present invention in an amount of 0.01% to 10%, more preferably 0.01% to 5%, and most preferably 0.01% to 1% by weight of the composition. The inulin used in the present invention is purchased from Sigma Aldrich, USA.
[0021] The composition preferably comprises an oil having a Hansen total solubility parameter (δ t ) value. Preferred oils may be selected from one or more of isopropyl myristate, isopropyl palmitate, caprylic / capric triglyceride and benzyl alcohol. These oils are preferably included in the composition in an amount of 8 to 25 wt % by weight of the composition.
[0022] An emulsifying polymer is preferably included in the composition of the present invention. The emulsifying polymer is preferably a swelling polymer powder made from pure acrylic acid monomers, or a mixture of acrylic acid monomers and methacrylic acid monomers, and is preferably an acrylate / C 10-30 Alkyl Acrylate Crosspolymer (Acrylates / C 10-30 Alkyl Acrylate Crosspolymer) is a polymer with the chemical name, carbomer, or a mixture thereof. In one aspect, the polymer is a crosslinked or non-crosslinked homopolymer. In another aspect, the polymer is a crosslinked or non-crosslinked copolymer. The emulsifying polymer is multifunctional and is capable of emulsifying the composition, stabilizing the composition and / or establishing the viscosity of the composition. The use of a polymer emulsifier alone or in combination with other additional polymer emulsifiers is within the scope of the composition of the present invention. Exemplary but non-limiting acrylates / C 10-30 Alkyl acrylate crosspolymers are available from suppliers such as The Lubrizol Corporation under the trade names PEMULEN TM TR-1, PEMULEN TM TR-2, PEMULEN TM EZ-4U, Ultrez 20, Ultrez 21, 1382 and ETD 2020 is commercially available. Desirable carbomers for use in the compositions of the present invention include Ultrez 10 and 980, both commercially sold by The Lubrizol Corporation. The emulsifying polymer is included in the cosmetic composition in an amount of 0.01 to 5%, preferably 0.02 to 4%, more preferably 0.03 to 3%, based on the total weight of the composition. Even more preferably, the polymer is included in the cosmetic composition in an amount of 0.04 to 2% by weight, most preferably 0.05 to 1% by weight, based on the weight of the cosmetic composition, including all ranges subsumed therein.
[0023] The compositions of the present invention may additionally comprise one or more of a sunscreen, a photostabilizer, a skin lightening agent, a wrinkle reducing agent, and a colorant.
[0024] The composition may additionally include an organic sunscreen selected from one or both of the UVA and UVB sunscreen classes. Sunscreens include those materials commonly used to block ultraviolet rays. Exemplary compounds are derivatives of PABA, cinnamate, and salicylate. For example, avobenzophenone (Parsol ), octyl methoxycinnamate and 2-hydroxy-4-methoxybenzophenone (also known as oxybenzone). Octyl methoxycinnamate and 2-hydroxy-4-methoxybenzophenone are commercially available under the trademarks Parsol MCX and Benzophenone-3, respectively. The exact amount of sunscreen used in the composition can vary depending on the desired degree of protection against solar ultraviolet radiation. Additives that reflect or scatter the sun's rays can also be used. These additives include oxides, such as zinc oxide and titanium dioxide.
[0025] The composition of the present invention comprises a cosmetically acceptable vehicle which may act as a diluent, dispersant and / or carrier for the active substances used in the composition so as to facilitate their distribution when the composition is applied to the skin. Cosmetically acceptable carriers suitable for use in the present invention may be aqueous, anhydrous or emulsions; preferably aqueous or emulsions, wherein the emulsions are water-in-oil or oil-in-water emulsions, the latter being most preferred. When present, water generally constitutes the balance of the composition. Preferably, water is present in a concentration of 5 to 99%, more preferably 20 to 80%, and still more preferably 40 to 80%, by weight of the composition.
[0026] The composition of the present invention can be delivered in the form of a slurry, a cream, an emulsion or a gel, preferably in the form of a cream. For the composition in solid form, the preferred form is a cream, and further preferably a cream with a vanishing cream base. The vanishing cream base is one comprising 3 to 25wt% fatty acids. Optionally, the composition may comprise 0.1 to 10wt% soap. When included, the fatty acid is preferably a C10 to C22 fatty acid, more preferably a C16 to C18 fatty acid. Most preferably, the fatty acid is stearic acid or palmitic acid or a mixture thereof, and the soap is preferably the potassium salt of the fatty acid mixture. The fatty acid is typically hystric acid, which is essentially (usually about 90 to 95%) a mixture of 45% stearic acid and 55% palmitic acid. The most preferred cream is a cream with 3 to 25wt% fatty acids and 0.1 to 10wt% soap.
[0027] Preferably, the composition comprises an emollient. Examples of emollients that can be used in leave-on compositions include stearyl alcohol, glyceryl monoricinoleate, mink oil, isopropyl isostearate, isobutyl palmitate, isocetyl stearate, oleyl alcohol, isopropyl laurate, hexyl laurate, decyl oleate, octadecane-2-ol, isocetyl alcohol, eicosanol, behenyl alcohol, cetyl palmitate, silicone oils such as dimethyl polysiloxane, din-butyl sebacate, and the like. sebacate), isopropyl myristate, isopropyl palmitate, isopropyl stearate, butyl stearate, polyethylene glycol, triethylene glycol, lanolin, cocoa butter, corn oil, cottonseed oil, olive oil, palm kernel oil, rapeseed oil, safflower seed oil, evening primrose oil, soybean oil, sunflower seed oil, avocado oil, sesame seed oil, coconut oil, peanut oil, castor oil, acetylated lanolin alcohols, petroleum jelly, mineral oil, butyl myristate, isopropyl linoleate, lauryl lactate, myristyl lactate, decyl oleate, myristyl myristate, and mixtures thereof.
[0028] Preferably, the composition comprises a solvent. Examples of solvents that can be used in the composition include ethanol, isopropanol, acetone, ethylene glycol monoethyl ether, diethylene glycol monobutyl ether, diethylene glycol monoethyl ether, and mixtures thereof. The composition may comprise a polyol, which may be selected from one or more of glycerol, 1,3-butylene glycol, propylene glycol, 1,3-propanediol, pentanediol, hexylene glycol, and sorbitol.
[0029] Preferably, the composition comprises a powder. Examples of powders that can be used in the composition include chalk, talc, Fuller's earth, kaolin, starch, gums, colloidal silica sodium polyacrylate, tetraalkyl and / or trialkylaryl ammonium smectites, chemically modified magnesium aluminum silicate, organically modified montmorillonite, hydrated aluminum silicate, fumed silica, carboxyvinyl polymers, sodium carboxymethylcellulose, ethylene glycol monostearate, and mixtures thereof.
[0030] Preferably, the composition comprises a preservative to prevent the growth of potentially harmful microorganisms. Examples of ingredients that can be used as preservatives in the composition include alkyl esters of p-hydroxybenzoic acid, hydantoin derivatives, propionates and various quaternary ammonium compounds. More preferably, ingredients that can be used as preservatives in the composition are sodium benzoate, iodopropynyl butyl carbamate, methylisothiazolinone, iodopropynyl butyl carbamate, phenoxyethanol, methylparaben, propylparaben, imidazolidinyl urea, sodium dehydroacetate, ethylhexylglycerol, benzyl alcohol, alkanediol and mixtures thereof. When present in the composition, the preservative is preferably added in an amount of 0.001 to 5wt%, more preferably in an amount of 0.01 to 3wt%, most preferably in an amount of 0.02 to 2wt%, and even most preferably in an amount of 0.25 to 1.5wt%.
[0031] Preferably, the composition comprises a range of other optional ingredients including antioxidants, binders, buffers, colorants, astringents, fragrances, sunscreens, conditioners, exfoliants, pH adjusters, skin sensates, skin soothing agents and skin healing agents.
[0032] It is within the scope of the present invention that the compositions claimed herein are eco-friendly and therefore do not contain specific ingredients that are increasingly implicated in long-term damage to the environment. Therefore, one aspect of the present invention relates to compositions that do not contain sulfate surfactants. Another aspect herein relates to compositions that do not contain preservatives. Yet another aspect relates to compositions that do not contain acrylate polymers. Compositions that do not contain titanium dioxide are also within the scope of the present invention. Green (i.e., biodegradable chelating agents are preferred) are used in such compositions, i.e., the composition preferably does not contain conventional chelating agents such as EDTA. According to the present invention, "free of" specific ingredients means that the composition contains less than 0.1, preferably less than 0.05, and further preferably less than 0.01% of the ingredients by weight of the composition. They are optimally not present in the composition.
[0033] The packaging for the compositions of the present invention may be a patch, bottle, tube, roller ball applicator, propellant driven aerosol device, squeeze container or lidded jar.
[0034] In another aspect, the invention relates to the use of a composition according to the invention for skin lightening.
[0035] In yet another aspect, the present invention relates to a method of lightening human skin, the method comprising the step of applying to the skin a composition according to the present invention.
[0036] In yet another aspect of the present invention, there is provided a method of providing microbiome benefits to the skin, the method comprising the step of applying to the skin a composition according to the present invention.
[0037] Inulin is known as a prebiotic to deliver beneficial effects to the intestinal microbiota. It stimulates the growth and activity of health-promoting microorganisms while inhibiting intestinal pathogenic bacteria. Beneficial microorganisms ferment inulin and produce acids, including short-chain fatty acids, which lower the pH in the colon and inhibit pathogens. The inventors have found that including inulin in the topical compositions of the present invention helps produce beneficial metabolites, which in turn can promote skin health, for example, inulin fermented by Staphylococcus epidermidis can deliver the benefit of depigmentation.
[0038] The invention will now be illustrated by the following non-limiting examples.
[0039] Example
[0040] Examples AF, 1, 2: % of cellular melanin content of various combinations of active substances relative to the control
[0041] Various samples containing active substances were prepared and the cellular melanin content % was measured. The protocol used to measure cellular melanin is summarized as follows:
[0042] Cell culture:
[0043] Neonatal primary human epidermal melanocytes were obtained from Life Technologies. Melanocytes were maintained in Medium 254 (MGM) supplemented with human melanocyte growth supplement. HaCaT keratinocytes were maintained in DMEM medium containing 10% heat-inactivated FBS. All culture media were also supplemented with 10 U / mL penicillin G and 0.1 mg / mL streptomycin sulfate. Both cell types were maintained in a humidified incubator at 37°C with a 5% CO2 atmosphere. Cell maintenance and subculture were performed according to the manufacturer's instructions.
[0044] To establish co-cultures, 40,000 cells each of HaCaT keratinocytes and melanocytes were mixed in 1 ml of a 1:1 mixture of MGM:KGM (KGM: Epilife medium supplemented with human keratinocyte growth supplement) and seeded per well in a 12-well Nunc plate.
[0045] Active ingredients added:
[0046] The active substances were prepared in culture medium and added to the cells at the tested concentrations together with the relevant controls 24 hours after inoculation. After 72 hours of active substance treatment, cell viability (using the calcein method) and measurements of the cellular melanin content were determined as described below.
[0047] Cell viability assay:
[0048] In brief, spent culture medium was removed and cells were washed once with 0.4 mL of phosphate buffered saline. Fresh 1 μM calcein-acetoxymethyl phosphate buffered saline was added to each well. The plate was incubated for 30 minutes at 37°C in an incubator under 5% CO2. Calcein fluorescence (excitation at 490 nm and emission at 520 nm) was measured using a TECAN M1000 plate reader.
[0049] Melanin content determination:
[0050] After obtaining the calcein fluorescence reading, the culture fluid of the cells was drained and fresh 0.15mL of 1N NaOH (in 10% DMSO) was added to each well. The cells were lysed by resuspending and incubating (60°C for 1 hour). Then, 0.1mL of the lysate was transferred to a new 384-well plate and OD was measured at 405nm in a TECAN M1000 plate reader. Melanin content was calculated as the percentage of cell melanin relative to the control.
[0051] The following samples given in Table-1 were prepared and the melanin content % measured for each sample is also given in the table.
[0052] Table-1
[0053] Example Active substance used (wt%) Cellular melanin% A Comparison 100 B Inulin (0.125%) 86 C Inulin (0.0625%) 96 D DMSO 100 E 4-Hexylresorcinol (0.0002%) 69* F COM1 97 1 COM1 + Inulin (0.125%) <![CDATA[74 *# ]]> 2 COM1 + Inulin (0.0625%) <![CDATA[70 *#$ ]]>
[0054] COM1 refers to a combination of niacinamide (0.0122%) + 4-hexylresorcinol (0.00002%) + retinyl propionate (0.00003%).
[0055] * means p<0.05 compared with Example D
[0056] # means p<0.05 compared with Example F
[0057] $ means p<0.05 compared with Example C
[0058] The data in Table-1 above show that the compositions according to the present invention (Examples 1 and 2) provide significantly superior reduction in cellular melanin content compared to the corresponding individual ingredients. The results of Example-2 are comparable to the very effective positive control (Example E).
[0059] It should be understood that the above experiment is carried out in an in vitro assay to assess the melanin % at the cellular level. It is expected that the actual concentration to be used for the preparation of the composition for topical use will be completely different. Due to the following reasons affecting the difference in concentration in large batches (in the bulk), therefore, compared to the concentration in the cellular level, the actual concentration to be used for the preparation of the composition for topical use is generally higher than several orders of magnitude. The composition can be formulated into an emulsion or gel with very many additional ingredients. The concentration of the desired active substance in the oil phase and the concentration in the aqueous phase are expected to be very different. They can also have very different physical properties and fluid dynamic properties, such as partition coefficient, diffusion rate, convection transmission rate, rheological properties, etc. Therefore, it is expected that, compared to the concentration in the cellular level, i.e., the concentration at which the experiment was carried out, the concentration to be used will be very different when formulated as a composition, generally higher than several orders of magnitude.
Claims
1. A personal care composition comprising: (a) a retinoic acid precursor selected from one or more of retinol esters, retinol, retinal and retinoic acid; (b) a carboxylic acid-functionalized aromatic heterocyclic compound selected from one or more of nicotinic acid, picolinic acid, nicotinic acid esters, nicotinamide and pyridineamide; (c) alkylresorcinol; (d) inulin; and (e) a cosmetically acceptable carrier.
2. The composition according to claim 1, comprising 0.001 to 10% by weight of the retinoic acid precursor.
3. The composition according to claim 1 or 2, comprising 0.01 to 10 wt% of the carboxylic acid functionalized aromatic heterocyclic compound.
4. The composition of any one of the preceding claims, wherein the alkylresorcinol comprises one or more of 4-hexylresorcinol, 4-ethylresorcinol, 4-phenylethylresorcinol, 4-cyclopentylresorcinol, 4-cyclohexylresorcinol and 4-octylresorcinol.
5. A composition according to any one of the preceding claims comprising from 0.001 to 10% by weight of alkylresorcinol.
6. A composition according to any preceding claim comprising 0.01 to 10% inulin.
7. A composition according to any one of the preceding claims, additionally comprising an oil, preferably selected from one or more of isopropyl myristate, isopropyl palmitate, caprylic / capric triglycerides and benzyl alcohol.
8. A composition according to any one of the preceding claims, further comprising an emulsifying polymer selected from the group consisting of acrylates / C 10-30 One or more of alkyl acrylate crosspolymer and carbomer, preferably, the emulsifying polymer is present in an amount of 0.01 to 5% by weight of the composition.
9. A composition according to any one of the preceding claims in the form of a serum, cream, emulsion or gel, preferably in the form of a serum or cream.
10. A method of providing brightness and even skin tone to the skin, the method comprising the step of applying to the skin a composition according to any one of the preceding claims.
11. A method of providing microbiome benefits to the skin, the method comprising the step of applying to the skin a composition according to any one of the preceding claims.
